Hoth Therapeutics, Inc. Made Big Gain

Hoth Therapeutics, Inc. (HOTH:NASDAQ) shot up at $1.36, a gain of 92%. On Wed, May 27, 2026, HOTH:NASDAQ touched a New 2-Week High of $1.36. The stock got featured on our News Catalysts scanner on Wed, May 27, 2026 at 05:04 PM in the 'BIOTECH' category. From Wed, May 13, 2026, the stock recorded 55.56% Up Days and 70.00% Green Days

About Hoth Therapeutics, Inc. (HOTH:NASDAQ)

Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.